Pfizer Inc (PFE)
Official siteHEALTHCARE • DRUG MANUFACTURERS - GENERAL • NYSE
Market Cap: $164.67B
Last updated: Nov 17, 2026 at 11:06 AM ET
Pfizer Inc (PFE) P/E Ratio & Valuation History
Pfizer (PFE) trades at 9.5x trailing earnings and 2.6x sales. Its P/E of 9.5x is above its 5-year median of 8.5x. Its forward P/E is 9.7x. The median P/E across 9 similar companies is 21.4x.
Current Multiples
Its forward P/E is above its trailing P/E, which implies earnings per share about 2.1% lower over the next year. PEG is left out because the growth rate behind it, P/E divided by PEG, is under 2% a year.
| Multiple | Value |
|---|---|
| P/E (trailing) | 9.5x |
| Forward P/E | 9.7x |
| Price to sales | 2.6x |
| Price to book | 1.8x |
| EV/EBITDA | 21.0x |
| Price to FCF | 14.0x |
| EV/FCF | 19.1x |
| PEG | N/A |
| FCF yield | 7.2% |
Historical Medians
Against its 10-year medians, its P/E is 24.6% below 12.6x, its P/S is 29.7% below 3.7x and its P/B is 41.9% below 3.1x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/E | 9.5x | 8.5x | 12.6x |
| P/S | 2.6x | 2.5x | 3.7x |
| P/B | 1.8x | 1.8x | 3.1x |
Valuation History
Over the 10 year ends shown, its P/E ranged from 7.7x in 2025 to 15.7x in 2023. 2025 was the lowest of those years.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $24.90 | 7.7x | 2.3x | 1.6x |
| 2024 | $26.53 | 8.5x | 2.4x | 1.7x |
| 2023 | $28.79 | 15.7x | 2.7x | 1.8x |
| 2022 | $51.24 | 7.8x | 2.9x | 3.1x |
| 2021 | $59.05 | 13.4x | 4.1x | 4.4x |
| 2020 | $36.81 | 13.5x | 4.9x | 3.3x |
| 2019 | $39.18 | 13.3x | 5.3x | 3.5x |
| 2018 | $43.65 | 14.6x | 6.3x | 4.0x |
| 2017 | $36.22 | 13.7x | 4.1x | 3.1x |
| 2016 | $32.48 | 13.6x | 3.8x | 3.4x |
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About PFE
What is PFE's forward P/E ratio?
Pfizer has a forward P/E ratio of 9.7x.
Is PFE stock overvalued?
GNG's valuation label for PFE is Fairly valued. Its P/E of 9.5x compares with a median of 21.4x across 9 similar companies.
What is PFE's price to sales ratio?
Pfizer has a price to sales ratio of 2.6x.
What is Pfizer's average P/E ratio over 5 years?
Pfizer's median P/E over the last 5 years is 8.5x, from 60 month-end values through Oct 2026.
PFE pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts